Insulin Enhances the Viability of Doxorubicin-Treated Luminal A Breast Cancer T-47D Cells
Insulin affects the viability of Luminal A breast cancer T-47D cells exposed to doxorubicin, indicating reduced cellular sensitivity to the cytotoxic effects of doxorubicin.